Breztri Aerosphere (Budesonide/Formoterol Fumarate/Glycopyrronium Bromide) is a combination small molecule formulation that works as a glucocorticoid receptor agonist, mAChRs antagonist, and 2AR agonist, intended for the treatment of chronic obstructive pulmonary disease (COPD)
In the Phase 2b VESPER program, weekly dosing achieved ~16% weight loss with no plateau through 32 weeks, successful transition to monthly maintenance, and favorable GI tolerability validating the feasibility of monthly GLP1 therapy
People taking Sermorelin can experience injection site reactions, including irritation, itching, sensitivity, swelling, redness, and pain
CAFs significantly increase the catabolism of BCAAs and the secretion of BCKAs in the nutrient-poor tumor microenvironment (TME)